Cargando…
Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries
The spinal anesthesia has the definitive advantage that profound nerve block can be produced in a large part of the body by the relatively simple injection of a small amount of local anesthetic. BACKGROUND AND AIMS: The use of adjuvant drugs with local anesthetics for spinal is intended to improve t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683476/ https://www.ncbi.nlm.nih.gov/pubmed/26712975 http://dx.doi.org/10.4103/0259-1162.159764 |
_version_ | 1782406030476443648 |
---|---|
author | Yadav, Monu Kumar, P. Bhanu Singh, Madhavi Gopinath, Ramachandran |
author_facet | Yadav, Monu Kumar, P. Bhanu Singh, Madhavi Gopinath, Ramachandran |
author_sort | Yadav, Monu |
collection | PubMed |
description | The spinal anesthesia has the definitive advantage that profound nerve block can be produced in a large part of the body by the relatively simple injection of a small amount of local anesthetic. BACKGROUND AND AIMS: The use of adjuvant drugs with local anesthetics for spinal is intended to improve the success of regional anesthesia. The present study evaluated magnesium sulfate in two different doses and fentanyl as an adjuvant to bupivacaine for spinal anesthesia. MATERIALS AND METHODS: Following Institutional Ethical Committee approval and written informed consent, a prospective randomized double-blinded study was conducted in 81 cases. Patients included were of either gender belonging to American Society of Anesthesiology (ASA) I or ASA II status undergoing elective infraumbilical surgeries of <3 h. Patients were randomized into four groups and were administered an intrathecal solution of (1) Group NS: 3 cc of 0.5% bupivacaine + 0.5 cc of NS. (2) Group F: 3 cc of 0.5% bupivacaine + 25 mcg fentanyl (0.5 cc). (3) Group M 50: 3 cc of 0.5% bupivacaine + 50 mg magnesium sulfate diluted to 0.5 cc with NS. (4) Group M 100: 3 cc of 0.5% bupivacaine + 100 mg magnesium sulfate diluted to 0.5 cc with NS. The variables assessed were visual analog pain scale, pruritus, intensity of motor block and somnolence before and after intrathecal injection at 5, 10, 15, 30, 45, and 60 min in the 1(st) h, at every 30 min in next hour and then hourly thereafter. RESULTS: The mean duration of analgesia in normal saline group, fentanyl group, M 50 and M 100 groups are 272.8 (standard error [S.E.] of mean 22.9), 360.0 (S.E. of mean 28.8), 252.5 (S.E. of mean 15.0), 276.6 (S.E. of mean 29.5) min, respectively. CONCLUSION: The addition of magnesium sulfate in the two different doses (50, 100 mg) does not affect the quality of block or duration of analgesia. However, M 100 is as effective as fentanyl as far as the duration of analgesia is concerned. |
format | Online Article Text |
id | pubmed-4683476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46834762015-12-28 Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries Yadav, Monu Kumar, P. Bhanu Singh, Madhavi Gopinath, Ramachandran Anesth Essays Res Original Article The spinal anesthesia has the definitive advantage that profound nerve block can be produced in a large part of the body by the relatively simple injection of a small amount of local anesthetic. BACKGROUND AND AIMS: The use of adjuvant drugs with local anesthetics for spinal is intended to improve the success of regional anesthesia. The present study evaluated magnesium sulfate in two different doses and fentanyl as an adjuvant to bupivacaine for spinal anesthesia. MATERIALS AND METHODS: Following Institutional Ethical Committee approval and written informed consent, a prospective randomized double-blinded study was conducted in 81 cases. Patients included were of either gender belonging to American Society of Anesthesiology (ASA) I or ASA II status undergoing elective infraumbilical surgeries of <3 h. Patients were randomized into four groups and were administered an intrathecal solution of (1) Group NS: 3 cc of 0.5% bupivacaine + 0.5 cc of NS. (2) Group F: 3 cc of 0.5% bupivacaine + 25 mcg fentanyl (0.5 cc). (3) Group M 50: 3 cc of 0.5% bupivacaine + 50 mg magnesium sulfate diluted to 0.5 cc with NS. (4) Group M 100: 3 cc of 0.5% bupivacaine + 100 mg magnesium sulfate diluted to 0.5 cc with NS. The variables assessed were visual analog pain scale, pruritus, intensity of motor block and somnolence before and after intrathecal injection at 5, 10, 15, 30, 45, and 60 min in the 1(st) h, at every 30 min in next hour and then hourly thereafter. RESULTS: The mean duration of analgesia in normal saline group, fentanyl group, M 50 and M 100 groups are 272.8 (standard error [S.E.] of mean 22.9), 360.0 (S.E. of mean 28.8), 252.5 (S.E. of mean 15.0), 276.6 (S.E. of mean 29.5) min, respectively. CONCLUSION: The addition of magnesium sulfate in the two different doses (50, 100 mg) does not affect the quality of block or duration of analgesia. However, M 100 is as effective as fentanyl as far as the duration of analgesia is concerned. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4683476/ /pubmed/26712975 http://dx.doi.org/10.4103/0259-1162.159764 Text en Copyright: © 2015 Anesthesia: Essays and Researches http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Yadav, Monu Kumar, P. Bhanu Singh, Madhavi Gopinath, Ramachandran Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
title | Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
title_full | Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
title_fullStr | Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
title_full_unstemmed | Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
title_short | Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
title_sort | intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683476/ https://www.ncbi.nlm.nih.gov/pubmed/26712975 http://dx.doi.org/10.4103/0259-1162.159764 |
work_keys_str_mv | AT yadavmonu intrathecalmagnesiumsulfateasaspinaladjuvantintwodifferentdosescombinedwith05heavybupivacaineforinfraumbilicalsurgeries AT kumarpbhanu intrathecalmagnesiumsulfateasaspinaladjuvantintwodifferentdosescombinedwith05heavybupivacaineforinfraumbilicalsurgeries AT singhmadhavi intrathecalmagnesiumsulfateasaspinaladjuvantintwodifferentdosescombinedwith05heavybupivacaineforinfraumbilicalsurgeries AT gopinathramachandran intrathecalmagnesiumsulfateasaspinaladjuvantintwodifferentdosescombinedwith05heavybupivacaineforinfraumbilicalsurgeries |